9535.0000 -84.50 (-0.88%)
NSE Sep 28, 2026 14:09 PM
Volume: 273.7K
 

BOB Capital Markets Ltd.
Q3 sales/EBITDA/PAT were 0.6%/7.5%/22.3% above our estimates. PAT was higher than estimated due to the adoption of the new tax regime
Divi's Laboratories .. has an average target of 7062.83 from 6 brokers.
More from Divi's Laboratories Ltd.
Recommended